Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye
- 4 November 2016
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 31 (1) , 93-99
Abstract
The aim of this study was to compare preoperative SPECT/CT with gamma-probe and methylene blue-dye (MBD) in the identification of sentinel lymph node (SLN) in early stage endometrial cancer. 40 stage-I EC patients (66.7 ± 9.7 years) underwent preoperative lymphoscintigraphy. After about 3 h from Tc-99m-albumin nanocolloid cervical injection, all patients underwent SPECT/CT study. MBD was injected into the cervix just before surgery under general anesthesia. All patients underwent SLN biopsy, hysterectomy, bilateral salpingo-oophorectomy, and radical regional lymphadenectomy. SPECT/CT findings were compared to those of gamma-probe and MBD techniques. In 2 patients no nodal migration was observed, neither with MBD nor radiotracer. Detection rate of at least one SLN was 90% (36/40 patients) with SPECT/CT, 88% (35/40) intra-operatively with gamma-probe and 80% (32/40) with MBD. Only in 7/40 patients a bilateral migration was obtained with all considered modalities. In particular, bilateral detection was achieved in 26 patients with SPECT/CT, in 24 with gamma-probe and in 10 patients with MBD. The concordance site between SPECT/CT and intraoperative gamma-probe was 73% (29/40 patients: 2 without migration, 21 bilateral and 6 monolateral SLNs); while concordance site with MBD was found in 40% (16/40: 8 bilateral, 6 monolateral SLNs, 2 without SLNs). Overall, 628 LNs were dissected (mean 18 LNs per patient). The median number of SLNs removed was 2 (mean 2.5 per patient). Out of 91 SLNs: 43 were “hot and blue (HB)”, 10 were blue only and 38 were hot only. LN metastases rate was 16%: 9/90 SLNs (7 HB, 2 hot only) were positive for metastases in 6 patients. Four non-SLNs were found positive in 3 patients, and all presented concomitant positive SLNs. False negative rate was 0%. SPECT/CT had the highest detection rate and achieved the highest rate of bilateral mapping, compared to gamma-probe and MDB. SPECT/CT had moderate concordance with gamma-probe, and it can help the intraoperative detection of SLNs providing important information about their anatomic location.Keywords
This publication has 34 references indexed in Scilit:
- Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancerNuclear Medicine Communications, 2013
- The Increasing Credibility of Sentinel Lymph Node Mapping in Endometrial CancerAnnals of Surgical Oncology, 2012
- Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imagingGynecologic Oncology, 2012
- Integration of Hybrid Single-Photon Emission Computed Tomography/Computed Tomography in the Preoperative Assessment of Sentinel Node in Patients With Cervical and Endometrial CancerInternational Journal of Gynecological Cancer, 2012
- Further considerations on adverse reactions to radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studiesGynecologic Oncology, 2011
- Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancyGynecologic Oncology, 2010
- Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancerGynecologic Oncology, 2009
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast CancerAnesthesia & Analgesia, 2002